News & Updates

A screen-and-prevent strategy for preterm preeclampsia (PE), which involves screening in the first trimester and low-dose aspirin prophylaxis for high-risk women in <16–36 weeks of gestation, will be launched in obstetric units of public hospitals across Hong Kong following promising results from a multicentre Asian trial led by the Chinese University of Hong Kong (CUHK) and a pilot programme at the Prince of Wales Hospital (PWH).

For the past three decades, intakes of sugar-sweetened beverages (SSBs) among children and adolescents across 185 countries have increased by nearly a quarter, reports a study. This increase matches the rise in obesity prevalence among young people worldwide.

Supplementing standard COVID-19 treatment with Spirulina – a nutrient-rich superfood – may improve recovery and reduce mortality in hospitalized COVID-19 patients, a study from Iran suggests.

Combination treatment with abemaciclib and a nonsteroidal aromatase inhibitor (NSAI) as initial therapy, compared with NSAI alone, helps extend survival in women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer, results of the MONARCH 3 study have shown.

A novel artificial intelligence (AI) classifier can detect hepatocellular carcinoma (HCC) signatures in routine blood tests up to 1 year before clinical diagnosis, as shown in a study from Hong Kong.